EPS Creative Health Technology Group Limited (HK:3860) has called an extraordinary general meeting to discuss and possibly approve a major transaction. The company plans to sell its entire issued share capital of EPS Innovative Medicine (Hong Kong) Limited to EPS Holdings, Inc.
The deal is valued at JPY1,250,000,001 and includes the sale of loans owed by the target company and related entities. This move could significantly reshape the company’s strategic focus and financial standing. Stakeholders and the market alike are expected to closely watch the outcome of the vote.
EPS Creative Health Technology Group Limited Stock Performance
- YTD Price Performance: 1.04%
- Average Trading Volume: 99,583
- Technical Sentiment Consensus Rating: Buy
- Current Market Cap: HK$250.6M
For further analysis of the 3860 stock, visit TipRanks’ Stock Analysis page.
